| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/18/1984 | EP0105804A2 Human monoclonal antibodies against bacterial toxins |
| 04/18/1984 | EP0105759A2 Human pancreatic GRF |
| 04/18/1984 | EP0105749A2 Compositions for use in inducing immunosuppression or immunoregulation of the immune response to an antigen |
| 04/18/1984 | EP0105736A1 Immobilization of proteins on polymeric supports |
| 04/18/1984 | EP0105481A1 Novel antigens and vaccines containing them |
| 04/17/1984 | US4443549 Antigens, cells, cultures |
| 04/17/1984 | US4443434 Octapeptide to inhibit gastric juice |
| 04/17/1984 | US4443427 Monoclonal antibody |
| 04/17/1984 | US4443368 Peptides affecting gonadal function |
| 04/17/1984 | US4443367 Synthetic |
| 04/17/1984 | US4442655 Foams, fleeces, wound healing, hemostatic, fillers, bones, supports, fibrin, thrombin, freeze drying |
| 04/17/1984 | CA1165711A1 Method for treating a casein-based raw material containing phosphocaseinates of bivalent cations, resulting products and applications thereof |
| 04/17/1984 | CA1165709A1 Antitumor antibacterial agents |
| 04/17/1984 | CA1165688A1 Adjuvants for rectal delivery of drug substances |
| 04/12/1984 | WO1984001379A1 Human pancreatic grf |
| 04/12/1984 | WO1984001378A1 Urotensin peptides |
| 04/11/1984 | EP0105141A2 Recombinant DNA molecules, process for their production, their use for production of hepatitis B surface antigen (HBsAg) and pharmaceutical compositions containing this HBsAg |
| 04/11/1984 | EP0105102A1 2-Aza-bicyclo(2,2,2)-octane-3-carboxylic-acid derivatives, process for their preparation, pharmaceutical preparations containing them and their application, and 2-aza-bicyclo(2,2,2)-octane-3-carboxylic acid as an intermediate and its preparation |
| 04/11/1984 | EP0105092A2 A thrombolytic agent |
| 04/10/1984 | US4442213 Process for the preparation of plasminogen and plasminogen thus prepared |
| 04/10/1984 | US4442089 Angiotensin converting enzyme |
| 04/10/1984 | US4442031 Immunopotentiating peptides |
| 04/10/1984 | US4441366 In a force sensing transducer |
| 04/10/1984 | CA1165245A1 Pharmaceutical preparations containing trh or its analogue |
| 04/10/1984 | CA1165237A1 Particles of lipoid-soluble substances, compositions containing said particles and biologically active substances adsorbed thereon, and a process for the preparation thereof |
| 04/04/1984 | EP0105014A2 Repair of tissue in animals |
| 04/04/1984 | EP0104964A1 Peptide derivatives as inhibitors of acid proteases |
| 04/04/1984 | EP0104933A2 Somatomedin growth promoter |
| 04/04/1984 | EP0104920A1 DNA sequences, recombinant DNA molecules and processes for producing swing growth hormone-like polypeptides |
| 04/04/1984 | EP0104630A2 Animal growth promotant and method of use for animal growth |
| 04/04/1984 | EP0104546A2 Therapeutic dipeptides |
| 04/04/1984 | EP0104461A2 Process for preparing antihypertensive 1-substituted cyclic lactam-2-carboxylic acids and their derivatives |
| 04/04/1984 | EP0104356A1 Highly purified human antihemophilic factor and method for the preparation thereof |
| 04/04/1984 | EP0104348A2 Fluorinated cyclic hexapeptide somatostatin analogs, process for their preparation, intermediate products for their preparation and pharmaceutical compositions containing them |
| 04/03/1984 | US4440904 Nonapeptide anti-secretory agents |
| 04/03/1984 | US4440761 Extracted from tissue of plant of genus carthamus |
| 04/03/1984 | US4440749 Preventive and treating agent for blood lipids abnormality and/or arteriosclerosis |
| 04/03/1984 | US4440747 Monoclonal antibody-ricin hybrids as a treatment of murine graft-versus-host disease |
| 04/03/1984 | US4440679 Pasteurized therapeutically active protein compositions |
| 04/03/1984 | US4440675 Human immune interferon |
| 04/03/1984 | CA1164714A1 Nutrition composition for pediatrics |
| 03/29/1984 | WO1984001149A1 Novel polypeptide and its use |
| 03/29/1984 | WO1984001108A1 Means for removing microorganisms from tissue |
| 03/29/1984 | WO1984001106A1 Repair of tissue in animals |
| 03/29/1984 | WO1984001090A1 Immune stimulator |
| 03/28/1984 | EP0104041A1 Enzyme inhibitors |
| 03/28/1984 | EP0103867A1 Phosphorus-containing peptide derivative |
| 03/28/1984 | EP0103858A2 New peptides, process for preparation thereof and pharmaceutical compositions containing them |
| 03/27/1984 | US4439521 Method for producing self-reproducing mammalian pancreatic islet-like structures |
| 03/27/1984 | US4439425 Peptide derivatives |
| 03/27/1984 | US4439424 Synthetic whole blood |
| 03/27/1984 | US4439423 Chymopapain and method for its use |
| 03/27/1984 | US4439421 Hydrophilic macromolecule, protein, polyol |
| 03/27/1984 | US4439364 Process for preparing antihypertensive 1-substituted cyclic lactam-2-carboxylic acids and their derivatives |
| 03/27/1984 | US4439360 Retro-inverso analogues of C-terminal penta and hexapeptides of Substance P |
| 03/27/1984 | US4439358 Method of preparing alpha-1-proteinase inhibitor |
| 03/27/1984 | US4439357 B-propiolactone |
| 03/27/1984 | CA1164473A1 Tolerizing and desensitizing compounds, compositions and methods of treatment against dermatological conditions caused by allergens from plants and trees of the anacardiaceae and giankgoaceae families |
| 03/27/1984 | CA1164375A1 Microbial expression of quasi-synthetic genes |
| 03/27/1984 | CA1164343A1 Pharmaceutical formulations containing prostaglandin |
| 03/27/1984 | CA1164342A1 Fibronectin compositions and methods of isolation therefor |
| 03/27/1984 | CA1164341A1 Isolation of plasminogen activators useful as therapeutic and diagnostic agents |
| 03/21/1984 | EP0103409A2 Glycolytic promoters for regulated protein expression: protease inhibitor |
| 03/21/1984 | EP0103395A2 DNA sequences, recombinant DNA molecules and processes for producing bovine growth hormone-like polypeptides in high yield |
| 03/21/1984 | EP0103196A2 Pasteurized human fibrinogen, method of preparing it and its use |
| 03/21/1984 | EP0103077A2 Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions |
| 03/21/1984 | EP0102976A1 A process for producing an insulin preparation |
| 03/20/1984 | US4438270 α-Halomethyl derivatives of α-amino acids |
| 03/20/1984 | US4438208 Region-specific determinants for vitamin K dependent bone protein |
| 03/20/1984 | US4438144 Valine, leucine, isoleucine |
| 03/20/1984 | US4438104 Endorphins having placental or pancreatic origin |
| 03/20/1984 | US4438103 Organic compounds |
| 03/20/1984 | US4438102 Method of promoting tissue growth |
| 03/20/1984 | US4438100 Sterilized preserved, stable mucine-containing solutions |
| 03/20/1984 | US4438093 Oral composition containing dextranase and α-1,3 glucanase and a method for preventing and suppressing oral diseases using the same |
| 03/20/1984 | US4438032 Cultivating excretory proteins, and cloning dna |
| 03/20/1984 | US4438029 Synthetic peptides |
| 03/20/1984 | CA1163922A1 Method for stabilizing plasminogen |
| 03/15/1984 | WO1984000891A1 Method for making gamma globulin-containing compositions |
| 03/15/1984 | WO1984000890A1 Stabilized gamma globulin concentrate |
| 03/14/1984 | EP0102831A1 Production of antibodies |
| 03/14/1984 | EP0102801A2 An agent for inhibiting proliferation of malignant tumour cells |
| 03/13/1984 | US4436918 From a 2,5-dioxopyrrolidine compound |
| 03/13/1984 | US4436726 N-Acylpeptide compound, processes for the preparation thereof and the pharmaceutical compositions |
| 03/13/1984 | US4436724 Method of producing γ-globulin for intravenous injection and therapeutic agent produced thereby |
| 03/13/1984 | CA1163585A1 Nucleotidic sequence coding the surface antigen of the hepatitis b virus, carrier containing the nucleotidic sequence, preparation process and antigen so obtained |
| 03/13/1984 | CA1163517A1 Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid |
| 03/13/1984 | CA1163479A1 Programmable audiovisual apparatus |
| 03/07/1984 | EP0102319A1 Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections |
| 03/07/1984 | EP0101935A1 Process for the preparation of the C1 inactivator and its use |
| 03/07/1984 | EP0101929A1 Polypeptide-diesters, their production and use |
| 03/07/1984 | EP0101859A2 Apparatus for preparative gel electrophoresis, in particular for separating mixtures on a gradient gel polyacryl amide column |
| 03/07/1984 | EP0101685A1 Medicinal composition for the treatment of certain neuroviroses. |
| 03/06/1984 | US4435571 Chemical intermediate for enkephalin, analgesics, neuroleptic agents, and tranquilizers |
| 03/06/1984 | US4435385 Antidiabetic, antiulcer, and antisecretory agent, and growth regulator |
| 03/06/1984 | US4435318 Desalting citrated plasma |
| 03/01/1984 | WO1984000776A1 Interferon-alpha 6l |
| 03/01/1984 | WO1984000757A1 Process for the preparation of a concentrate of factor viii |
| 02/29/1984 | EP0101603A2 Protein (PP13), process for concentrating and obtaining it, and its use |
| 02/28/1984 | US4434160 For patients in post-agression phase |